ALLIANCEBERNSTEIN L.P. - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 133 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$558,000
-9.4%
381,953
-12.0%
0.00%
-100.0%
Q4 2016$616,000
-21.7%
434,153
-3.4%
0.00%0.0%
Q3 2016$787,000
+2.3%
449,6530.0%0.00%0.0%
Q2 2016$769,000
-13.2%
449,6530.0%0.00%0.0%
Q1 2016$886,000
+3.7%
449,6530.0%0.00%0.0%
Q4 2015$854,000
-0.6%
449,6530.0%0.00%0.0%
Q3 2015$859,000
-58.9%
449,653
-0.1%
0.00%
-50.0%
Q2 2015$2,089,000
+6.2%
450,1330.0%0.00%0.0%
Q1 2015$1,967,000
+21.3%
450,133
-3.7%
0.00%
+100.0%
Q4 2014$1,622,000
-17.2%
467,4330.0%0.00%
-50.0%
Q3 2014$1,959,000
-28.5%
467,4330.0%0.00%0.0%
Q2 2014$2,739,000
-7.0%
467,4330.0%0.00%
-33.3%
Q1 2014$2,945,000
+21.7%
467,433
+13.0%
0.00%
+50.0%
Q4 2013$2,420,000
-0.6%
413,695
-10.5%
0.00%0.0%
Q3 2013$2,435,000
-31.9%
462,085
-0.6%
0.00%
-50.0%
Q2 2013$3,578,000464,6520.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Camber Capital Management LP 7,500,000$34,800,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,983,710$32,404,0001.08%
DAFNA Capital Management LLC 189,000$877,0000.74%
Lyons Wealth Management, LLC. 56,665$264,0000.30%
Telemetry Investments, L.L.C. 110,000$510,0000.23%
Callan Capital, LLC 232,000$1,076,0000.23%
OXFORD ASSET MANAGEMENT LLP 968,446$4,494,0000.12%
FEDERATED HERMES, INC. 5,641,200$26,175,0000.08%
HRT FINANCIAL LP 31,973$148,0000.07%
WELLINGTON MANAGEMENT GROUP LLP 33,885,551$157,230,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders